<!DOCTYPE html>

<html>
<head>
<meta charset="utf-8"/>
<title>Head &amp; Neck Surgery - Clinic Guide</title>
<link href="https://cdnjs.cloudflare.com/ajax/libs/materialize/1.0.0/css/materialize.min.css" rel="stylesheet"/>
<link href="../css/style.css" rel="stylesheet"/>
</head>
<body>
<header>
<h1>Head &amp; Neck Surgery - Clinic Guide</h1>
<form action="../search.html" class="search-form" method="get">
<input name="q" placeholder="Search" required="" type="text"/>
<button class="btn waves-effect waves-light" type="submit">Search</button>
</form>
<div class="floating-nav">
<a class="btn" href="../index.html">Home</a>
<button class="btn" onclick="history.back()" type="button">Back</button>
</div>
</header>
<main class="container">
<h2 class="unnumbered" id="head-neck-surgery-clinic-guide">Head &amp;
Neck Surgery – Clinic Guide</h2>
<h3 class="unnumbered" id="dr.-olearys-clinic">Dr. O’Leary’s Clinic</h3>
<ol type="I">
<li><p>Correct the chief compliant. Put type/site of cancer TNM stage
and treatment (with date) at the beginning of every note (T2N1M0 HPV+
left base of tongue SCCa s/p concomitant chemoradiation with weekly
cisplatin completed on 10/13/2018.)</p></li>
<li><p>Use Dr O’Leary’s New patient or Follow up visit
templates</p></li>
<li><p>ALWAYS CC op-note to primary care physician, other care providers
(rad onc, med onc) and referring physician’</p></li>
<li><p>Spray the patients with Lidocaine/Afrin spray prior to presenting
to Dr. O’Leary so there is enough time for local anesthesia and
decongestion</p></li>
</ol>
<h3 class="unnumbered" id="dr.-weins-clinic">Dr. Wein’s Clinic</h3>
<p>1. if you can, dictate your notes and minimize the amount of
templating</p>
<p>2. always give patients a copy of their pathology, lab, or imaging
results at the time of an office visit</p>
<p>3. document and circle the appropriate spaces on the encounter form
if:</p>
<ul>
<li><p>smoking cessation advised</p></li>
<li><p>imaging/labs ordered or surgery booked</p></li>
<li><p>imaging/labs/path reviewed</p></li>
<li><p>procedures performed</p></li>
</ul>
<p>4. Always CC the corresponding MD at the end of the note with “CC:
Andrew Scott, MD”, and not with less formal approaches like “Dr. Scott,
PCP”</p>
<h3 class="unnumbered" id="dr.-tracys-clinic">Dr. Tracy’s Clinic</h3>
<p>1. Similar to Dr. O’Leary’s clinic flow</p>
<h3 class="unnumbered" id="burning-mouth-consults">Burning Mouth Consults</h3>
<p><em>Dr. O’Leary’s workup</em></p>
<ul>
<li>Obtain lab tests: ANA, SS-A, SS-B, TSH, fasting glucose, A1c, CBC w/ diff, ferritin, Vit B1, B2, B6, B12, folate, Mg2+, Zinc</li>
<li>Biopsy if visible lesion</li>
<li>Consider patch testing</li>
</ul>
<h3 class="unnumbered" id="aphthous-ulcer-treatments">Aphthous ulcer
treatments</h3>
<p>triamcinolone acetonide with carboxymethylcellulose paste (Kenalog in
Orabase)</p>
<p>Fluocinonide (Lidex) gel</p>
<p>Peridex mouthwash</p>
<p>Aphthasol paste – Aphthasol oral paste is usually applied 4 times
each day--usually after breakfast, lunch, and dinner, and at
bedtime.</p>
<p>Oral B12 melts (made by same company as Xylimelts)</p>
<h3 class="unnumbered" id="inspire-consults">Inspire Consults</h3>
<ul><li><p>Check diagnosis of sleep apnea: AHI, (must be btw 15-65 w/
&lt;25% central apneas) date of sleep study (should be in last 3 years).
Ask previous nasal, palate, tonsil surgeries. Still having daytime
fatigue. Check social hx: work history/driving problems. Ask about heart
failure/afib</p></li><li><p>Patients must be &gt;21yo. BMI&lt;32</p></li><li><p>Check CPAP usage: &lt;4 hours/&lt;5days tolerated and reasons for
poor tolerance (claustrophobia etc).</p></li><li><p>Contraindications: Pts w/ neuromuscular disorders or those who
can’t operate the remote at night. Pregnant pts. Pts w/ complete
concentric collapse of the soft palate of sleep endoscopy</p></li></ul>



<h3 class="unnumbered" id="thyroid-nodules">Thyroid Nodules</h3>
<ul><li><p>Nodules incidentally found on imaging </p>
<ol type="A">
<li><p>Should always be confirmed by Thyroid &amp; Cervical
U/S </p></li>
<li><p>Nodules &gt;1cm seen on PET scans that are confirmed on thyroid
U/S should get an FNA </p></li>
</ol></li><li><p>Initial workup of palpable or incidentally found nodules </p>
<ul><li><p><strong>TSH </strong>[Free T<sub>4</sub>]
and <strong>Ultrasound </strong> </p></li><li><p><strong>Normal or high TSH</strong> → no need for reuptake
radionuclide cscan </p></li><li><p><strong>Low</strong> TSH → get a Iodine<sup>123</sup> or
Technetium<sup>99</sup> reuptake scan </p>
<ol type="1">
<li><p>"Hot Nodule" → evaluate for hyperthyroidism </p></li>
<li><p>"Cold Nodules" have a 5% risk of cancer and should get an
ultrasound </p></li>
<li><p>Multiple nodules? Evaluate each one separately. </p>
<ul><li><p>If TSH low or normal. Get I<sup>123</sup> scan to see if there
are autonomous nodules  </p></li><li><p>FNA iso or nonfunctioning nodules. </p></li><li><p>FNA </p>
<ul><li><p>Don't bother if its completely cystic </p></li><li><p>Perform FNA if nodule is (A) &gt;2cm <strong> or </strong>(B) 
&gt;1cm + suspicious features </p></li><li><p>Suspicious Ultrasound features (70% chance of malignancy) </p>
<ul><li><p><strong><u>Hypo</u></strong>echoic - think hypOH DEAR ITS
CANCER </p>
<ul><li><p>partially cystic and iso/hyperechoic are less worrying features:
perform FNA if &gt;1.5cm </p></li></ul>
</li><li><p>Microcalcification or rim calcifications </p></li><li><p>Increased central vascularity </p></li><li><p>Tall than wide (think a Cachetic patient) = bad. Wider than tall
(fat person) = good </p></li><li><p>Irregular margins </p></li></ul>




<h4 class="unnumbered" id="bethesda-system---interpreting-results">Bethesda system -
Interpreting Results</h4>
<ol start="4" type="A">
<li><p>Malignant (99% risk) &amp; suspicious for malignancy (70%
risk) </p>
<ul><li><p>Go to Surgery   </p></li><li><p>Indeterminate cytology - Two types </p>
<ul><li><p>Follicular neoplasm or suspicious for follicular neoplasm or
Hurthle Cell (25% risk of malignancy) </p>
<ul><li><p>Pretty much all of these are surgically excised. Affirma to
supplement decision making </p></li><li><p>FLUS (follicular lesion of unknown significance) or Atypia of
undetermined significance — 14% risk </p>
<ul><li><p>Can observe or excise.  Affirma test can help you rule out
malignancy </p></li><li><p>Surgery: if excision is planned - do a lobectomy unless there are
reasons in the history that make us more suspicious for
malignancy  </p></li><li><p>Nondiagnostic—(around 1-4% risk):  </p>
<ul><li><p>repeat U/S guided FNA. Most people wait ~3months but should
repeat sooner if there are concerning U/S findings </p></li><li><p>Can excise if suspicious u/s findings or if its growth &gt;20% in
2 directions </p></li><li><p>Benign — 2.5% risk </p>
<ul><li><p>Follow up these patients </p>
<ul><li><p>Suspicious U/S features: repeat U/S &amp; FNA within 12
months </p></li><li><p>Otherwise repeat U/S in 12-24months and FNA if (a) growth &gt;20%
in 2 directions or (b) nodule develops suspicious features </p></li><li><p>You can stop following any nodule that's had two benign cytology
results. Its benign, get over it </p></li></ul>


<ol start="5" type="I">
<li><p>Follow Up </p>
<ul><li><p>Nodules that met criteria for FNA but were benign: see
above </p></li><li><p>Nodules that did not meet criteria for FNA </p></li><li><p>repeat U/S in 12-24months (you don't need to follow spongiform or
purely cyst nodules) </p></li><li><p>Nodules that are &gt;4cm or cause compressive symptoms can be
surgically removed </p></li><li><p>Preoperative: Guidelines recommend documentation of voice and
performing a FOE prior to Thyroid surgery on EVERY patient. Discuss risk
of thyroid surgery to voice. Discuss findings of FOE w/
anesthesia.</p></li><li><p>Perioperative: should identify RLN and SLN. Intraop nerve
monitoring is optional. No opinion on decadron</p></li><li><p>Postop: should perform FOE on patients w/ voice change post op.
If abnormal voice or VF mobility abnormality, patients should f/u with
SLP</p></li></ul>



id="improving-voice-outcomes-after-thyroid-surgery-clinical-practice-guideline"&gt;Improving
Voice Outcomes after Thyroid Surgery – Clinical Practice Guideline



<h3 class="unnumbered" id="adult-neck-mass-clinical-practice-guideline">Adult Neck Mass –
Clinical Practice Guideline</h3>
<ul><li><p>Don’t routinely give antibiotics unless other signs of infection
exist</p></li><li><p>Suspicious if: present for &gt;2 weeks w/o change in size
<u>or</u> if on exam mass is (1) fixed to adjacent structure (2) firm
(3) &gt;1.5cm or (4) has ulceration of overlying skin <u>or</u> history
highly suspicious</p>
<ul><li><p>In these patients, do targeted physical exam (FOE etc)</p></li><li><p>Strongly recommend CT neck (U/S or MRI ok) or performing an FNA
on these suspicious neck masses</p>
<ul><li><p>FNA should be done INSTEAD of an open biopsy</p></li><li><p>Cystic masses: don’t assume that they are benign</p></li><li><p>If testing is negative:</p>
<ul><li><p>Can either with open biopsy (should <u>always</u> be done with a
direct laryngoscopy)</p></li><li><p>Or could do additional testing (CBC, ANA, SSA/SSB, ESR, TSH, PTH,
EBV,CMV, PPD, Bartonella, Thyroid U/S, CT chest /w contrast,
Thyroglobulin FNA-needle wash assay</p></li></ul>

<h3 class="unnumbered" id="nerve-sheath-tumors">Nerve Sheath Tumors</h3>
<h4 class="unnumbered" id="paragangliomas-glomus-tumors">Paragangliomas
(Glomus tumors)</h4>
<p>Glomus Jugulare: supplied by ascending pharyngeal a.</p>
<p>Glomus Tympanicum: arise from Jacobson’s nerve (CNIX)</p>
<p>Carotid Body: MC in H&amp;N: internal carotid posterior and external
carotid anteriorly (Lyre sign)</p>
<p>Vagal paraganglioma: Displaces carotid anteriorly and medially</p>
<h3 class="unnumbered" id="salivary-glands">Salivary Glands</h3>
<p>Innervation:</p>
<ul>
<li>Sup. Salivary nuc → GSPN (pregang. parasymp.) [CN7] → pterygopalatine ganglion → lacrimal</li>
<li>Inf. Salivary nuc → Lesser petrosal [CN9] → Otic ganglion → auriculotemporal n. → parotid</li>
<li>Sup. Salivary nuc → Corda Tympani [CN7] → Submandibular ganglion → submandibular gland</li>
</ul>
<h3 class="unnumbered" id="melanoma">Melanoma</h3>
<ul><li><p>Ask about:</p>
<ul><li><p>Sunlight exposure, history of skin burns, family history
(xeroderma pigmentosum, familial atypical multiple mole melanoma
syndrome, dysplastic nevus syndrome)</p></li><li><p>Presents as a mole-like growth with "ABCD" (ABCD is diagnostic
not prognostic )</p>
<ul><li><p>Asymmetry, Borders are irregular. Color is not uniform. Diameter
&gt; 6 mm.</p></li><li><p>Workup:</p>
<ul><li><p>Ideally: excisional biopsy w/ 1-2mm narrow margins. If too large,
can do punch biopsy however this is subject to sampling error so if
negative, strongly consider repeating. This will give you information to
perform the wide local excision later.</p></li><li><p>Patients with:</p></li><li><p>Stage IB or higher: should get a CXR (r/o lung mets) LDH (eval
for liver mets)</p></li><li><p>Palpable LNs or imaging findings for enlarged LNs: get U/S guided
FNA to eval for metastatic LN disease</p></li><li><p>Stage III disease: some advocate for CT C/A/P to look for distant
mets (CT chest is most important)</p></li><li><p>Stage IV disease: PET-CT C/A/P, MRI head, refer for clinical
trials</p></li><li><p>Prognosis depends on variant: worse with ↑Breslow Depth,
ulceration, M&gt;F, and Head/Neck location</p>
<ul><li><p>Occiput and cheek most common sites of H&amp;N</p></li><li><p>Markers</p>
<ul><li><p>HMB-45 (specific). S-100 sensitive. Melan A. MART-1</p></li><li><p>Variants include</p>
<ul><li><p>Superficial spreading—most common subtype; dominant early radial
growth results in good prognosis.</p></li><li><p>Lentigo maligna melanoma (LMM)—lentiginous proliferation (radial
growth); best prognosis. Associated with sun-exposed skin and the
elderly</p></li><li><p>Nodular—blue/blackish, looks like hemangiomaearly vertical
growth; poor prognosis</p></li><li><p>Acral lentiginous—arises on the palms or soles, often in
dark-skinned individuals; not related to UV light exposure</p></li><li><p>Desmoplastic-Neurotropic Melanoma (DM): often are amelanotic.
High rate of recurrence</p></li><li><p>Clark levels: <u>only useful for prognosis in T1 lesions.</u></p>
<ul><li><p><strong>epidermis</strong> only = stage I.</p></li><li><p><strong>Into papillary</strong> dermis = II.</p></li><li><p><strong>All of papillary</strong> dermis =III.</p></li><li><p>Invades <strong>reticular</strong> dermis = IV.</p></li><li><p>Into <strong>subcutaneous</strong> tissue: V</p></li><li><p>Melanoma TNM Staging</p></li></ul>





<table>
<colgroup>
<col style="width: 36%"/>
<col style="width: 31%"/>
</colgroup>
<thead>
<tr class="header">
<th></th>
<th>N0</th>
<th>N1</th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td>T1a</td>
<td>IA</td>
<td>III</td>
<tr class="even">
<td>T1b</td>
<td>IB</td>
<td>T2a</td>
<td>T2b</td>
<td>IIA</td>
<td>T3a</td>
<td>T3b</td>
<td>IIB</td>
<td>T4a</td>
<td>T4b</td>
<td>IIC</td>
</tr></tr></tbody>
</table>
<p>Survival: T1 95%, T2 80-95%, T3:40-85%. T4:10-30%</p>
<ul><li><p>Treatment</p>
<ul><li><p>Surgical margins</p></li></ul>
<blockquote>
<p>Tis = 0.5mm margin</p>
<p>T1 (&lt;1mm) = 1cm margin.</p>
<p>T2 (1-2mm): do 1-2cm margin</p>
<p>T3+ (&gt;2mm): do 2cm</p>
</blockquote>
<ol start="2" type="A">
<li><p>T2/T3/T4</p>
<ul><li><p>Adjuvant: may consider interferon alpha 2b (Stage III+)</p></li><li><p>N0 neck: consider sentinel LN biopsy (SLNB). Especially if</p>
<ul><li><p>&lt;60 yo especially for tumors w/o ulceration, Ulceration, High
mitotic rate, Angiolymphatic invasion, Clark level IV</p></li><li><p>N1-N3: Neck dissection</p>
<ul><li><p>Superficial parotidectomy + MRND if primary location is:
anterior/lateral scalp, temple, lateral forehead, lateral cheek , ear
(basically anything anterior to the plane of the EACs)</p></li><li><p>Level II-V neck dissection: If primary is scalp/occiput posterior
to the coronal plane of the EACs.</p></li><li><p>Special considerations:</p>
<ul><li><p>Lentigo maligna melanoma (LMM) — tends to have subclinical spread
(often has positive margins). After resection, take a circumferential
"square" margin (Anderson et al. Johnson et al.)</p></li><li><p>Chemo:</p>
<ul><li><p>Interferon alpha-2b — use for stage III, consider for T2+
lesions. Can cause hepatic and cardiac toxicity.</p></li><li><p>Dacarbazine (DTIC) — stage IV</p></li><li><p>Sentinel LN biopsy (SLNB) w/ pre-operative lymphoscintigraphy</p>
<ul><li><p>2-4 hours preop, patients get radioactive colloid into melanoma.
Inject methylene blue into melanoma (dermis). Dissect out the hottest
radiactive node and all other nodes that are above 10% of the cpm value
of the hottest node.</p></li></ul>
<p><a href="../index.html">Back to homepage</a></p>
</li></ul>

</li></ul>
</li></ul>

</li></ul>
</li></ul>
</li></ol></li></ul></li></ul>




</li></ul>
</li></ul>
</li></ul>





</li></ul>
</li></ul>
</li></ul></li></ul>

</li></ul>
</li></ul>
</li></ol></li></ul></li></ul>

</li></ul>

</li></ul>
</li></ul></li></ul>
</li></ol></li></ul>

</li></ul>

</li></ol></li></ul>

</li></ul>
</main>
<script src="https://cdnjs.cloudflare.com/ajax/libs/materialize/1.0.0/js/materialize.min.js"></script>
</body>
</html>
